CANF Financing Cash Flow

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Financing Cash Flow

CANF Financing Cash Flow

Latest reported$10.04Mperiod endingJun 30, 2026

CANF TTM Cash from Financing ($4.64M → $10.04M)

TTM financing cash flow

Share image ↗High-resolution chart · PNG

CANF financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Financing Cash Flow — Trailing twelve months (TTM) (USD)

Period ending	Financing Cash Flow (USD)
Jun 30, 2026	10,043,000
Mar 31, 2026	9,843,500
Dec 31, 2025	9,644,000
Sep 30, 2025	9,864,000
Jun 30, 2025	10,084,000
Mar 31, 2025	8,397,500
Dec 31, 2024	6,711,000
Sep 30, 2024	3,355,500
Jun 30, 2024	0
Mar 31, 2024	0
Dec 31, 2023	0
Sep 30, 2023	0
Jun 30, 2023	0
Mar 31, 2023	0
Dec 31, 2022	0
Sep 30, 2022	0
Jun 30, 2022	0
Mar 31, 2022	0
Dec 31, 2021	0
Sep 30, 2021	0
Jun 30, 2021	0
Mar 31, 2021	0
Dec 31, 2020	0
Sep 30, 2020	0
Jun 30, 2020	0
Mar 31, 2020	0
Dec 31, 2019	0
Sep 30, 2019	0
Jun 30, 2019	0
Mar 31, 2019	0
Dec 31, 2018	0
Sep 30, 2018	0
Jun 30, 2018	0
Mar 31, 2018	0
Dec 31, 2017	0
Sep 30, 2017	0
Jun 30, 2017	0
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0
Dec 31, 2015	0
Sep 30, 2015	0
Jun 30, 2015	0
Mar 31, 2015	0
Dec 31, 2014	0
Sep 30, 2014	5,971,925
Jun 30, 2014	5,971,925
Mar 31, 2014	6,475,757
Dec 31, 2013	13,046,190
Sep 30, 2013	7,151,558
Jun 30, 2013	7,161,205
Mar 31, 2013	8,049,097
Dec 31, 2012	1,510,159
Sep 30, 2012	5,998,330
Jun 30, 2012	6,002,013
Mar 31, 2012	4,610,289
Dec 31, 2011	4,643,042
Sep 30, 2011	3,173,487